ไทย
Appoints Phillip Securities as Lead Underwriter, Finalizes IPO Price at THB 1.20
SKIN has appointed Phillip Securities (PCL), or PST, as the lead underwriter and underwriter for its ordinary shares, along with four other securities firms as co-underwriters. The company has finalized its initial public offering (IPO) price at THB 1.20 per share for a total of 44 million shares. The subscription period is open from September 15-17, 2025, in preparation for listing on the Market for Alternative Investment (mai).
Joins Forces with 5 Leading Brokerages for Share Distribution
Dr. Somphob Sakpunpanom, Chairman of Asset Pro Management Company Limited (APM), as the financial advisor to Skin Laboratory Public Company Limited (SKIN), stated that SKIN has signed an agreement to appoint Phillip Securities (Thailand) Public Company Limited as the lead underwriter and underwriter for its initial public offering of newly issued ordinary shares. Four other co-distributors and underwriters include AIRA Securities Public Company Limited, Beyond Securities Public Company Limited, CGS International Securities (Thailand) Company Limited, and Liberator Securities Company Limited.
Share Structure Revealed: 44 Million Shares Offered, Representing 30.55%
Mr. Sommsak Sirichainarumitr, Chief Executive Officer of Asset Pro Management Company Limited (APM), as the financial advisor to Skin Laboratory Public Company Limited (SKIN), stated that SKIN currently has a registered capital of THB 72 million, divided into 144 million ordinary shares with a par value of THB 0.50 per share, and a paid-up capital of THB 50 million. The company will offer 44 million IPO shares, representing 30.55% of the total issued and paid-up ordinary shares post-IPO, and will list all its ordinary shares on the Market for Alternative Investment (mai) to foster future growth and business opportunities.
PST Deems THB 1.20 Price Appropriate, Citing Strong Fundamentals and Expecting Positive Investor Reception
Mr. Vicha Tomana, Managing Director, Investment Banking at Phillip Securities (Thailand) Public Company Limited (PST), as the lead underwriter, stated that SKIN’s IPO offering of 44 million shares has been priced at THB 1.20 per share for investors. The subscription period is set for September 15-17, 2025, and the shares are expected to begin trading on the Market for Alternative Investment (mai) in September 2025, under the Consumer Products industry group, with the trading symbol “SKIN”.
The determination of the IPO price is deemed appropriate and in line with current market conditions. It is expected that SKIN will be well-received by investors due to its strong fundamentals, solid financial position, and significant opportunities for business growth, driven by the popular domestic beauty market trend, as well as its readiness to expand its business and launch new products in the future.
CEO Reveals Vision, Highlighting 2 Main Brands and Comprehensive Distribution Channels
Mr. Chanwit Khiaonavawongsa, Chief Executive Officer of Skin Laboratory Public Company Limited (SKIN), stated that SKIN’s business involves conceiving, developing, and distributing skincare products. The company co-develops formulas with certified quality manufacturers under its two main brands: Skinsista and the cosmeceutical brand Dermie. In 2025, both brands are targeted to launch no less than 20 new SKUs.
Popular product categories among consumers include serums, creams, sunscreens, and well-received foundation powders. The company’s products are available in modern trade retail stores, including both Convenience Stores and Specialty Stores such as Watsons, CJ MORE NINE BEAUTY, 7-11, Beautrium, Konvy, etc., and on online channels like Shopee, Lazada, and Tiktok shop.
IPO Proceeds Plan Revealed: Product Development and Expansion into Domestic and International Markets
Following the fundraising, the company plans to use the proceeds as working capital to drive long-term growth. This will be allocated to investment for further developing existing products, and research and development for new products in the cosmetics, cosmeceutical skincare, and health product categories to expand its product base and enhance market competitiveness.
Furthermore, the proceeds will be used for marketing and public relations expenses to build awareness for the Skinsista and Dermie brands, with a budget for expanding distribution channels to cover target groups nationwide, as well as in international markets, to support continuous growth.
